Credit Suisse Ag Mirati Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$41.99 - $62.38 $20.4 Million - $30.3 Million	-485,093 Reduced 89.07%	59,533 $3.5 Million
Q3 2023 Nov 13, 2023	BUY	$27.8 - $45.35 $143,892 - $234,731	5,176 Added 0.96%	544,626 $23.7 Million
Q2 2023 Aug 11, 2023	BUY	$36.13 - $49.49 $581,078 - $795,947	16,083 Added 3.07%	539,450 $19.5 Million
Q1 2023 May 10, 2023	BUY	$36.54 - $54.26 $83,420 - $123,875	2,283 Added 0.44%	523,367 $19.5 Million
Q4 2022 Feb 13, 2023	BUY	$41.27 - $98.62 $3.25 Million - $7.76 Million	78,711 Added 17.79%	521,084 $23.6 Million
Q3 2022 Nov 10, 2022	SELL	$59.5 - $86.7 $20,051 - $29,217	-337 Reduced 0.08%	442,373 $30.9 Million
Q2 2022 Aug 12, 2022	BUY	$39.16 - $88.71 $43,976 - $99,621	1,123 Added 0.25%	442,710 $29.7 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $4.35 Million - $8.66 Million	57,385 Added 14.94%	441,587 $36.3 Million
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $1.64 Million - $2.36 Million	-12,425 Reduced 3.13%	384,202 $56.4 Million
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $101,343 - $136,104	767 Added 0.19%	396,627 $70.2 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $7.72 Million - $9.64 Million	53,614 Added 15.67%	395,860 $63.9 Million
Q1 2021 May 14, 2021	BUY	$158.92 - $221.61 $30.3 Million - $42.2 Million	190,483 Added 125.51%	342,246 $58.6 Million
Q4 2020 Feb 12, 2021	SELL	$162.05 - $240.27 $6.4 Million - $9.49 Million	-39,489 Reduced 20.65%	151,763 $33.3 Million
Q3 2020 Nov 13, 2020	SELL	$113.26 - $167.27 $2.03 Million - $3 Million	-17,959 Reduced 8.58%	191,252 $31.8 Million
Q2 2020 Aug 12, 2020	BUY	$72.01 - $120.39 $4.24 Million - $7.08 Million	58,846 Added 39.14%	209,211 $23.9 Million
Q1 2020 May 13, 2020	BUY	$69.78 - $116.21 $1.08 Million - $1.79 Million	15,424 Added 11.43%	150,365 $11.6 Million
Q4 2019 Feb 12, 2020	SELL	$70.76 - $128.86 $5.24 Million - $9.54 Million	-74,048 Reduced 35.43%	134,941 $17.4 Million
Q3 2019 Nov 12, 2019	SELL	$77.91 - $109.6 $2.14 Million - $3.01 Million	-27,471 Reduced 11.62%	208,989 $16.3 Million
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $2.57 Million - $4.52 Million	-43,180 Reduced 15.44%	236,460 $24.4 Million
Q1 2019 May 14, 2019	SELL	$43.65 - $78.95 $7.84 Million - $14.2 Million	-179,663 Reduced 39.12%	279,640 $20.5 Million
Q4 2018 Feb 13, 2019	BUY	$32.0 - $47.43 $316,640 - $469,319	9,895 Added 2.2%	459,303 $19.5 Million
Q3 2018 Nov 13, 2018	BUY	$47.1 - $62.7 $20 Million - $26.6 Million	424,202 Added 1682.94%	449,408 $21.2 Million
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $344,224 - $692,413	13,214 Added 110.19%	25,206 $1.24 Million
Q1 2018 May 15, 2018	BUY	$17.2 - $34.95 $206,262 - $419,120	11,992 New	11,992 $368,000
Q3 2017 Nov 14, 2017	SELL	$4.7 - $11.7 $207,819 - $517,338	-44,217 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	44,217	44,217 $161,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account